Updates

13
Nov

GE Healthcare and Lantheus Medical Imaging have launched a second phase III clinical trial for Lantheus' flurpiridaz F-18 investigational PET radiopharmaceutical.

Full Text

15
Aug

SPECT has the lion’s share of the market for radiopharmaceuticals to diagnose disease, but PET’s catching up as the market continues to grow on rising demand from China and India, according to a new research teaser.

The MarketsandMarkets report, “Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) –... Read More

20
Jun

New clinical indications and positive reimbursement for cardiac studies could cause PET radiopharmaceutical sales to grow more than tenfold in the U.S. in coming years, to more than $4 billion by 2018, according to a new report from market research firm Bio-Tech Systems.

U.S. PET radiopharmaceutical sales could... Read More